Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Sectoral Asset Management Inc
Form 13F · Q2 2026

Sectoral Asset Management Inc

CIK 1274413申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$1.4亿
申报组合市值
82
持仓数量
12
Quarters on record
Top 50
持仓数量

Sectoral Asset Management Inc——持仓

共 82 个持仓中的前 50 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1CTNM Contineum Therapeutics Inc727,587+0.0%$1193万8.3%
2SI Shoulder Innovations Inc430,407+0.0%$873万6.1%
3LLY Eli Lilly & Co6,354+0.0%$762万5.3%
4UNH Unitedhealth Group Inc13,235−11.5%$550万3.8%
5JNJ Johnson & Johnson18,218+0.0%$463万3.2%
6ORKA Oruka Therapeutics Inc41,987—$400万2.8%
7BNTX Biontech Se41,869+88.9%$390万2.7%
8DFTX Definium Therapeutics Inc78,310—$368万2.6%
9DXCM Dexcom Inc50,756+118.5%$342万2.4%
10RCUS Arcus Biosciences Inc110,870+146.0%$342万2.4%
11AMGN Amgen Inc9,210+0.0%$334万2.3%
12SMMT Summit Therapeutics Inc220,180+216.3%$321万2.2%
13IRTC Irhythm Holdings Inc26,070—$310万2.2%
14ABBV Abbvie Inc12,200+0.0%$307万2.1%
15MRK Merck & Co Inc21,480+0.0%$277万1.9%
16AVBP Arrivent Biopharma Inc79,043+163.4%$275万1.9%
17VRTX Vertex Pharmaceuticals Inc5,432−22.5%$270万1.9%
18ARGX Argenx Se2,831−20.6%$263万1.8%
19GILD Gilead Sciences Inc20,620−25.0%$261万1.8%
20INSM Insmed Inc23,216+18.0%$248万1.7%
21TECX Tectonic Therapeutic Inc71,009+272.6%$244万1.7%
22ISRG Intuitive Surgical Inc5,850+11.4%$233万1.6%
23IMTX Immatics N.V224,928+236.6%$228万1.6%
24SYK Stryker Corporation7,129+21.4%$225万1.6%
25AVTX Avalo Therapeutics Inc119,923—$222万1.5%
26CBIO Crescent Biopharma Inc.121,300—$218万1.5%
27ROIV Roivant Sciences Ltd61,100+88.0%$216万1.5%
28IQV Iqvia Hldgs Inc10,848+30.6%$210万1.5%
29PLSE Pulse Biosciences Inc67,895—$188万1.3%
30DHR Danaher Corp Del9,597+0.0%$183万1.3%
31TMO Thermo Fisher Scientific Inc3,508+0.0%$176万1.2%
32ABT Abbott Laboratories18,080−29.3%$164万1.1%
33ATEC Alphatec Hldgs Inc185,900—$161万1.1%
34BSX Boston Scientific Corp36,330+4.5%$155万1.1%
35TMDX Transmedics Group Inc21,950—$146万1.0%
36CYTK Cytokinetics Inc16,330+123.7%$139万1.0%
37REGN Regeneron Pharmaceuticals2,169−25.7%$135万0.9%
38CVS Cvs Health Corp13,000—$134万0.9%
39EW Edwards Lifesciences Corp14,826−14.5%$134万0.9%
40TRVI Trevi Therapeutics Inc65,596−11.9%$122万0.9%
41BMY Bristol-Myers Squibb Co21,150+0.0%$122万0.9%
42VERA Vera Therapeutics Inc25,573+0.0%$110万0.8%
43COGT Cogent Biosciences Inc26,740+20.8%$103万0.7%
44MDT Medtronic Plc11,100+0.0%$88万0.6%
45TARS Tarsus Pharmaceuticals Inc13,285+17.9%$84万0.6%
46KURA Kura Oncology Inc71,480+0.0%$78万0.5%
47CNC Centene Corp Del12,000—$77万0.5%
48UTHR United Therapeutics Corp Del1,370−19.9%$74万0.5%
49HNGE Hinge Health Inc8,744−28.6%$73万0.5%
50NKTR Nektar Therapeutics10,111−6.8%$71万0.5%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。